Clinical Trials Logo

Nocturia clinical trials

View clinical trials related to Nocturia.

Filter by:

NCT ID: NCT06239883 Recruiting - Clinical trials for Obstructive Sleep Apnea

This Research Project Studies the Relationship Between OSA and Nocturia.

Start date: June 1, 2019
Phase:
Study type: Observational

The main goal of the study is to explore the relationship between obstructive sleep apnoea and nocturia.

NCT ID: NCT06222515 Completed - Clinical trials for Stress Urinary Incontinence

Bladder Diary for Female Storage LUTS

Start date: July 1, 2009
Phase:
Study type: Observational

Storage urinary symptoms are the most complained of lower urinary tract symptoms (LUTS) and need further classification. This original study aims to derive a novel classification algorism for female storage LUTS according to a 3-day bladder diary (BD). Further feasibility of the application was also evaluated.

NCT ID: NCT06110091 Recruiting - Insomnia Clinical Trials

Multi-center Trial to Improve Nocturia and Sleep in Older Adults

MINT
Start date: December 5, 2023
Phase: N/A
Study type: Interventional

The Multi-center Trial to Improve Nocturia and Sleep in Older Adults (MINT) study is a randomized trial to determine and assess the efficacy of integrated treatment of coexisting nocturia and insomnia, as well as explore the effects of this treatment on quality of life.

NCT ID: NCT06091566 Recruiting - Clinical trials for Urinary Incontinence

Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)

Start date: January 12, 2024
Phase: N/A
Study type: Interventional

UCon is a medical device for treatment of the symptoms of overactive bladder (OAB) and bowel dysfunction (BD). It electrically stimulates the DGN through the skin to obtain modulated behaviour of the bladder/bowel musculature e.g., suppress undesired bladder/bowel activity to relieve the symptoms of the patient. This clinical investigation is designed as a single-arm, prospective, multi-centre, and early feasibility study.

NCT ID: NCT05874375 Recruiting - Clinical trials for Urinary Incontinence

UCon Treatment of Overactive Bladder (OAB) in Males

Start date: October 12, 2023
Phase: N/A
Study type: Interventional

UCon is a medical device for treatment of the symptoms of OAB and fecal incontinence (FI). It electrically stimulates the DGN through the skin to obtain modulated behaviour of the bladder musculature e.g., suppress undesired bladder activity to relieve the symptoms of the patient. This clinical investigation is a randomized, cross-over, single-site, prospective, early feasibility study, which is used to evaluate Ucon with respect to its initial clinical safety and device performance in a small number of males with OAB.

NCT ID: NCT05604222 Recruiting - Nocturia Clinical Trials

Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women

SLAB
Start date: March 5, 2023
Phase: Phase 4
Study type: Interventional

Urgency urinary incontinence (UUI) is common in older people and vastly reduces quality of life, yet the cause and mechanism of disease are not well understood. This study will investigate the role of adding behavioral sleep intervention to the standard pharmacotherapy in treatment of UUI among older adults, and the brain mechanisms involved in continence by evaluating brain changes. This will expand the current knowledge of how the sleep affects bladder control, and better characterize the brain mechanisms in maintaining continence.

NCT ID: NCT05597020 Completed - Nocturia Clinical Trials

A Post Approval Study to Investigate the Efficacy of Daridorexant in Subjects With Insomnia and Comorbid Nocturia

Start date: January 18, 2023
Phase: Phase 4
Study type: Interventional

A post approval study to investigate the efficacy of daridorexant in subjects with insomnia and comorbid nocturia

NCT ID: NCT05562388 Recruiting - Clinical trials for Obstructive Sleep Apnea

Mandibular Advancement Device and Changes in Nocturia

MAD
Start date: July 31, 2023
Phase: N/A
Study type: Interventional

The main purpose of this study is to test is mandibular advacenment device (MAD) use is associated with reductions in nocturia.

NCT ID: NCT05551377 Active, not recruiting - Parkinson Disease Clinical Trials

Head-up Tilt Sleeping to Alleviate Orthostatic Hypotension, Supine Hypertension and Nocturia in Parkinson's Disease

Start date: January 18, 2023
Phase: N/A
Study type: Interventional

Autonomic dysfunction is common and often underrecognized in Parkinson's disease (PD). Orthostatic hypotension (OH) affects up to a third of PD patients and often coincides with supine hypertension. This co-occurrence complicates pharmacological treatment as treatment of one can negatively affect the other. Head-up tilt sleeping (HUTS) could improve both. This phase II randomized controlled trial (RCT) aims to investigate the efficacy and tolerability of this understudied intervention, leading to optimal implementation strategies.

NCT ID: NCT05464589 Completed - Overactive Bladder Clinical Trials

Effects of Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in Adults

Start date: August 10, 2021
Phase: N/A
Study type: Interventional

For overactive bladder symptoms, there are numerous physiotherapy techniques have been found to be beneficial. Transcutaneous electrical stimulation of the tibial nerve is one of those treatment options, that is entirely a non-invasive, easy to apply, and cost-effective technique. Transcutaneous stimulation of the tibial nerve targets the sacral nerve plexus that contracts the pelvic floor muscles and controls the bladder function. This research aims to study the effectiveness of transcutaneous tibial nerve stimulation in adults with overactive bladder symptoms along with the conventional physiotherapy for overactive bladder (pelvic floor muscle training through Kegel's exercises) among 60 patients with overactive bladder symptoms on the basis of non-probability purposive sampling technique with screening for study criteria through a consultant urologist. After taking informed consent, all participants will be randomly allocated into two groups. Group A will receive pelvic floor muscles training through Kegels exercises along with transcutaneous electrical stimulation of the tibial nerve and Group B will receive pelvic floor muscles training through Kegels exercises. The treatment duration will of six weeks. Outcomes will be assessed before the start of the treatment and after the end of the treatment sessions.